Biohaven Ltd.
BHVN
$38.97
$0.431.12%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -41.12% | -13.53% | -28.16% | 64.95% | -192.08% |
| Total Depreciation and Amortization | 23.15% | -16.00% | 11.04% | 379.36% | -8.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 966.18% | 24.76% | 36.65% | -98.40% | 643.40% |
| Change in Net Operating Assets | -413.45% | -93.28% | 482.49% | -982.48% | 97.73% |
| Cash from Operations | -21.17% | -113.58% | 42.82% | -2.96% | 21.09% |
| Capital Expenditure | 62.34% | -109.75% | 19.05% | -145.00% | 93.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -105.76% | -22.19% | 23,818.83% | 99.88% | -- |
| Cash from Investing | -106.68% | -23.22% | 7,300.57% | 99.60% | -5,735.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 93.23% | -94.98% | -176.27% | -89.16% | 92.82% |
| Cash from Financing | 718.41% | -94.98% | -176.27% | -94.97% | 315.69% |
| Foreign Exchange rate Adjustments | -675.00% | 75.31% | -1,180.00% | -96.50% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 266.05% | -768.66% | 121.84% | -127.21% | 596.26% |
